A detailed history of Aspect Partners, LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Aspect Partners, LLC holds 136 shares of LEGN stock, worth $4,119. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136
Holding current value
$4,119
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 23, 2026

BUY
$30.29 - $33.72 $4,119 - $4,585
136 New
136 $2.96 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.07B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Aspect Partners, LLC Portfolio

Follow Aspect Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspect Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspect Partners, LLC with notifications on news.